ARCHIVES

Award Fees Show House NCI thinks FCRF Contractors Are Performing

This article is from The Cancer Letter archive.

Vol. 12 No. 33 | August 15, 1986

Download PDF Visit The Full Archive

Related Articles

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

Group Backing Epstein Received Grants From Reynolds Foundation

May 15, 1992

NCI Budget: About Half Of Increase In President’s Budget Would Fund Grants

February 13, 1998

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

December 27, 2013